4-Methoxyphenyl 4-(3,4,5-Trimethoxybenzyl)-1-Piperazineacetate Monofumarate Monohydrate (KB-5492), a New Anti-Ulcer Agent With a Selective Affinity for the Sigma Receptor, Prevents Cysteamine-Induced Duodenal Ulcers in Rats by a Mechanism Different From That of Cimetidine.
The Japanese Journal of Pharmacology
doi 10.1254/jjp.64.221
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 1994
Authors
Publisher
Japanese Pharmacological Society